Uncle Sam's Orders: Emergent Scores $107 Mil. For Anthrax Plant, While Bavarian Nordic Delivers On Smallpox

Government funding for the BioThrax plant suggests there are doubts other new treatments will be ready soon. But funding for the BioShield program may be reduced during congressional debate on appropriations.

More from Archive

More from Pink Sheet